Your browser doesn't support javascript.
loading
Safety and immunogenicity of the measles vector-based SARS-CoV-2 vaccine candidate, V591, in adults: results from a phase 1/2 randomised, double-blind, placebo-controlled, dose-ranging trial.
Vanhoutte, Frédéric; Liu, Wen; Wiedmann, Richard T; Haspeslagh, Liesbeth; Cao, Xin; Boundy, Keith; Aliprantis, Antonios; Davila, Michelle; Hartzel, Jonathan; Li, Jianing; McGuire, Mac; Ramsauer, Katrin; Tomberger, Yvonne; Tschismarov, Roland; Brown, Deborah D; Xu, Weifeng; Sachs, Jeffrey R; Russell, Kevin; Stoch, S Aubrey; Lai, Eseng.
Afiliação
  • Vanhoutte F; SGS Life Sciences, Antwerp, Belgium.
  • Liu W; Merck & Co., Inc., Kenilworth, NJ, USA.
  • Wiedmann RT; Merck & Co., Inc., Kenilworth, NJ, USA.
  • Haspeslagh L; Merck & Co., Inc., Kenilworth, NJ, USA.
  • Cao X; Merck & Co., Inc., Kenilworth, NJ, USA.
  • Boundy K; Merck & Co., Inc., Kenilworth, NJ, USA; Currently at AlloVir, Inc., Cambridge, MA, USA.
  • Aliprantis A; Merck & Co., Inc., Kenilworth, NJ, USA; Currently at Flagship Pioneering, Boston, MA, USA.
  • Davila M; Merck & Co., Inc., Kenilworth, NJ, USA.
  • Hartzel J; Merck & Co., Inc., Kenilworth, NJ, USA.
  • Li J; Merck & Co., Inc., Kenilworth, NJ, USA.
  • McGuire M; Merck & Co., Inc., Kenilworth, NJ, USA.
  • Ramsauer K; Themis Bioscience GmbH, Vienna, Austria, a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA.
  • Tomberger Y; Themis Bioscience GmbH, Vienna, Austria, a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA.
  • Tschismarov R; Themis Bioscience GmbH, Vienna, Austria, a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA.
  • Brown DD; Merck & Co., Inc., Kenilworth, NJ, USA.
  • Xu W; Merck & Co., Inc., Kenilworth, NJ, USA.
  • Sachs JR; Merck & Co., Inc., Kenilworth, NJ, USA.
  • Russell K; Merck & Co., Inc., Kenilworth, NJ, USA.
  • Stoch SA; Merck & Co., Inc., Kenilworth, NJ, USA.
  • Lai E; Merck & Co., Inc., Kenilworth, NJ, USA. Electronic address: eseng_lai@merck.com.
EBioMedicine ; 75: 103811, 2022 Jan.
Article em En | MEDLINE | ID: mdl-35042081
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunogenicidade da Vacina / Vacinas contra COVID-19 / Vetores Genéticos / SARS-CoV-2 / COVID-19 / Vírus do Sarampo Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunogenicidade da Vacina / Vacinas contra COVID-19 / Vetores Genéticos / SARS-CoV-2 / COVID-19 / Vírus do Sarampo Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article